List of Excipients in API primaquine phosphate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing primaquine phosphate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | CARNAUBA WAX | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | CELLULOSE, MICROCRYSTALLINE | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | FERRIC OXIDE RED | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | HYPROMELLOSE 2910 | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | LACTOSE | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | MAGNESIUM STEARATE | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | POLYETHYLENE GLYCOL 400 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing primaquine phosphate
Detailed excipient profiles for primaquine phosphate
Excipient focus: CARNAUBA WAX
primaquine phosphate drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
primaquine phosphate drug variants containing CELLULOSE, MICROCRYSTALLINE
primaquine phosphate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
primaquine phosphate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| Bayshore Pharmaceuticals LLC | primaquine phosphate | 76385-102 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
primaquine phosphate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| Bayshore Pharmaceuticals LLC | primaquine phosphate | 76385-102 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
primaquine phosphate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
primaquine phosphate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FERRIC OXIDE RED
Excipient focus: HYPROMELLOSE 2910
primaquine phosphate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| Bayshore Pharmaceuticals LLC | primaquine phosphate | 76385-102 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
primaquine phosphate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| Bayshore Pharmaceuticals LLC | primaquine phosphate | 76385-102 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
primaquine phosphate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
primaquine phosphate drug variants containing LACTOSE MONOHYDRATE
primaquine phosphate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
primaquine phosphate drug variants containing MAGNESIUM STEARATE
primaquine phosphate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
primaquine phosphate drug variants containing POLYETHYLENE GLYCOL 400
primaquine phosphate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
primaquine phosphate drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
primaquine phosphate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing POLYSORBATE 80
Excipient focus: STARCH, CORN
primaquine phosphate drug variants containing STARCH, CORN
primaquine phosphate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
primaquine phosphate drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TALC
primaquine phosphate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| Bayshore Pharmaceuticals LLC | primaquine phosphate | 76385-102 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
primaquine phosphate drug variants containing TITANIUM DIOXIDE
primaquine phosphate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
primaquine phosphate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing TRIACETIN
Excipient focus: WATER
primaquine phosphate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| Bayshore Pharmaceuticals LLC | primaquine phosphate | 76385-102 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
